Literature DB >> 9573262

Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles.

S Laquerre1, D B Anderson, R Argnani, J C Glorioso.   

Abstract

Herpes simplex virus type 1 (HSV-1) glycoprotein B (gB) resides in the virus envelope in an oligomeric form and plays an essential role in virus entry into susceptible host cells. The oligomerizing domain is a movable element consisting of amino acids 626 to 653 in the gB external domain. This domain contains a single cysteine residue at position 633 (Cys-633) that is predicted to form an intramolecular disulfide bridge with Cys-596. In this study, we examined gB oligomerization, processing, and incorporation into mature virus during infection by two mutant viruses in which either the gB Cys-633 [KgB(C633S)] or both Cys-633 and Cys-596 [KgB(C596S/C633S)] residues were mutated to serine. The result of immunofluorescence studies and analyses of released virus particles showed that the mutant gB molecules were not transported to the cell surface or incorporated into mature virus envelopes and thus infectious virus was not produced. Immunoprecipitation studies revealed that the mutant gB molecules were in an oligomeric configuration and that these mutants produced hetero-oligomers with a truncated form of gB consisting of residues 1 to 43 and 595 to 904, the latter containing the oligomerization domain. Pulse-chase experiments in combination with endoglycosidase H treatment determined that the mutant molecules were improperly processed, having been retained in the endoplasmic reticulum (ER). Coimmunoprecipitation experiments revealed that the cysteine mutations resulted in gB misfolding and retention by the molecular chaperones calnexin, calreticulin, and Grp78 in the ER. The altered conformation of the gB mutant glycoproteins was directly detected by a reduction in monoclonal antibody recognition of two previously defined distinct antigenic sites located within residues 381 to 441 and 595 to 737. The misfolded molecules were not transported to the cell surface as hetero-oligomers with wild-type gB, suggesting that the conformational change could not be corrected by intermolecular interactions with the wild-type molecule. Together, these experiments confirmed that a disulfide bridge involving Cys-633 and Cys-596 is not essential for oligomerization but rather is required for proper folding and maintenance of a gB domain essential to complete posttranslational modification, transport, and incorporation into mature virus particles.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573262      PMCID: PMC110055          DOI: 10.1128/JVI.72.6.4940-4949.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.

Authors:  S D Marlin; S L Highlander; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants.

Authors:  P E Pellett; K G Kousoulas; L Pereira; B Roizman
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

3.  Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B.

Authors:  J M Chapsal; L Pereira
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain.

Authors:  S Laquerre; S Person; J C Glorioso
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Disulfide bonds of herpes simplex virus type 2 glycoprotein gB.

Authors:  N Norais; D Tang; S Kaur; S H Chamberlain; F R Masiarz; R L Burke; F Marcus
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  The isolation and characterization of mutants of herpes simplex virus type 1 that induce cell fusion.

Authors:  V C Bond; S Person; S C Warner
Journal:  J Gen Virol       Date:  1982-08       Impact factor: 3.891

8.  Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1.

Authors:  D J Bzik; B A Fox; N A DeLuca; S Person
Journal:  Virology       Date:  1984-03       Impact factor: 3.616

9.  Herpes simplex virus type 1 DNA cleavage and encapsidation require the product of the UL28 gene: isolation and characterization of two UL28 deletion mutants.

Authors:  L A Tengelsen; N E Pederson; P R Shaver; M W Wathen; F L Homa
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum.

Authors:  P S Kim; P Arvan
Journal:  J Cell Biol       Date:  1995-01       Impact factor: 10.539

View more
  7 in total

1.  Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.

Authors:  William J Britt; Michael A Jarvis; Derek D Drummond; Michael Mach
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Acidic pH Mediates Changes in Antigenic and Oligomeric Conformation of Herpes Simplex Virus gB and Is a Determinant of Cell-Specific Entry.

Authors:  Darin J Weed; Stephen J Dollery; Tri Komala Sari; Anthony V Nicola
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity?

Authors:  A W Purcell; A Todd; G Kinoshita; T A Lynch; C L Keech; M-J Gething; T P Gordon
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

4.  Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection.

Authors:  Radeekorn Akkarawongsa; Nina E Pocaro; Gary Case; Aaron W Kolb; Curtis R Brandt
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

5.  Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.

Authors:  Robert Dinser; Frank Zaucke; Florian Kreppel; Kjell Hultenby; Stefan Kochanek; Mats Paulsson; Patrik Maurer
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells.

Authors:  S Laquerre; D B Anderson; D B Stolz; J C Glorioso
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 7.  Herpes virus fusion and entry: a story with many characters.

Authors:  Roselyn J Eisenberg; Doina Atanasiu; Tina M Cairns; John R Gallagher; Claude Krummenacher; Gary H Cohen
Journal:  Viruses       Date:  2012-05-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.